Ana Laus to Middle Aged
This is a "connection" page, showing publications Ana Laus has written about Middle Aged.
Connection Strength
0.184
-
Laus AC, de Paula FE, de Lima MA, Carlos CD, Gomes INF, de Marchi P, Valente JKN, Pioltini ABM, Miziara JE, da Silva CM, Viana LS, Scapulatempo-Neto C, Reis RM. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Mol Biol Rep. 2019 Apr; 46(2):2417-2425.
Score: 0.046
-
de Carvalho AC, Laus AC, Lopes Junior HR, Porto J, Sant'Anna Silva D, Ribeiro AG, Datorre JG, Tavares RM, Sousa Carlos AB, Furquim T, Uno M, Chammas R, Villela P, Dos Reis MB, de Medeiros Matsushita M, Oliveira MA, Hirai WY, Guimar?es DP, Santos FA, Reis RM. Association of Genetic Ancestry and Colorectal Cancer Risk in a Large Brazilian Cohort: Replication of Single-Nucleotide Polymorphisms Identified by Genome-Wide Association Studies. JCO Glob Oncol. 2025 Jun; 11:e2400512.
Score: 0.018
-
Freitas AJA, Causin RL, Calfa S, Santana IVV, Balie M, Hirai W, Laus AC, Araujo HS, Hidalgo Filho CM, de Oliveira Bombarda F, da Silva VD, Evangelista AF, de P?dua Souza C, Reis RM, Marques MMC. Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes. Breast Cancer Res Treat. 2025 Jul; 212(2):237-250.
Score: 0.018
-
Sorroche BP, de Jesus Teixeira R, de Souza VG, Tosi IC, Tostes K, Laus AC, Santana IVV, de Lima Vazquez V, Arantes LMRB. CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival. J Mol Med (Berl). 2025 Jun; 103(6):725-737.
Score: 0.018
-
Zantut-Wittmann DE, Barreto IS, Laus AC, Moreno DA, Moma CA, Maia FFR, Assump??o LVMD, Reis RM. PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma. Mol Cell Endocrinol. 2023 06 15; 570:111931.
Score: 0.015
-
Petrilli JD, Ara?jo LE, da Silva LS, Laus AC, M?ller I, Reis RM, Netto EM, Riley LW, Arruda S, Queiroz A. Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases. Sci Rep. 2020 12 16; 10(1):22072.
Score: 0.013
-
Marczynski GT, Laus AC, Dos Reis MB, Reis RM, Vazquez VL. Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients. Sci Rep. 2020 10 29; 10(1):18682.
Score: 0.013
-
Leal LF, Laus AC, Cavagna R, de Paula FE, de Oliveira MA, Ribeiro DM, Hassan FM, Miziara JE, da Silva ECA, da Silva VD, De Marchi P, Reis RM. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients. Thorac Cancer. 2020 10; 11(10):2987-2992.
Score: 0.013
-
Dettogni RS, Stur E, Laus AC, da Costa Vieira RA, Marques MMC, Santana IVV, Pulido JZ, Ribeiro LF, de Jesus Parmanhani N, Agostini LP, Dos Reis RS, de Vargas Wolfgramm Dos Santos E, Alves LNR, Garcia FM, Santos JA, do Prado Ventorim D, Reis RM, Louro ID. Potential biomarkers of ductal carcinoma in situ progression. BMC Cancer. 2020 Feb 12; 20(1):119.
Score: 0.012
-
Arantes LM, Laus AC, Melendez ME, de Carvalho AC, Sorroche BP, De Marchi PR, Evangelista AF, Scapulatempo-Neto C, de Souza Viana L, Carvalho AL. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. Oncotarget. 2017 Feb 07; 8(6):9911-9921.
Score: 0.010
-
Sim?es-Sousa S, Granja S, Pinheiro C, Fernandes D, Longatto-Filho A, Laus AC, Alves CD, Su?rez-Pe?aranda JM, P?rez-Say?ns M, Lopes Carvalho A, Schmitt FC, Garc?a-Garc?a A, Baltazar F. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors. Cell Cycle. 2016 07 17; 15(14):1865-73.
Score: 0.009